Literature DB >> 2828694

Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections.

J A Mercer1, C A Wiley, D H Spector.   

Abstract

Spleen cells which replicate murine cytomegalovirus (MCMV) during acute infection in vivo were identified by electron microscopy and combined immunocytochemical staining and in situ cytohybridization. Most infected cells, as defined by in situ hybridization for viral RNA with MCMV-specific probes, were shown to be positive for factor VIII-related antigen and negative for Ia, Thy-1, and F4/80 antigens. Electron microscopic ultrastructural observations indicated that the infected cells in the spleen are predominantly sinusoidal-lining cells. We also studied reactivation of MCMV from latently infected mice by cocultivation of spleen cells with mouse embryo fibroblasts. Virus was only recovered from cells in preparations of stromal (or reticular) fragments, and not from spleen cell suspensions. Neither removal of immunoglobulin-bearing cells from the stromal fragments by panning nor depletion of Thy-1- and Ia-bearing stromal cells by treatment with monoclonal antibodies and complement reduced the frequency of reactivation of MCMV. These data suggest that T lymphocytes, mature B lymphocytes, and other Ia-bearing cells are not predominant reservoirs of latent MCMV.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2828694      PMCID: PMC253658          DOI: 10.1128/JVI.62.3.987-997.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Splenic necrosis in mice infected with cytomegalovirus.

Authors:  C A Mims; J Gould
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

2.  Factor 8 on the vascular intima: possible importance in haemostasis and thrombosis.

Authors:  A L Bloom; J C Giddings; C J Wilks
Journal:  Nat New Biol       Date:  1973-02-14

3.  Pulmonary cytomegalovirus infection in the adult.

Authors:  J E Craighead
Journal:  Am J Pathol       Date:  1971-06       Impact factor: 4.307

4.  Infection of adult mouse macrophages in vitro with cytomegalovirus.

Authors:  P J Tegtmeyer; J E Craighead
Journal:  Proc Soc Exp Biol Med       Date:  1968-12

5.  Effect of cortisone on nonfatal mouse cytomegalovirus infection.

Authors:  D Henson; R D Smith; J Gehrke; C Neapolitan
Journal:  Am J Pathol       Date:  1967-12       Impact factor: 4.307

6.  A study of some histochemical and phagocytic reactions of the sinus lining cells of the rabbit's spleen.

Authors:  M J Snodgrass
Journal:  Anat Rec       Date:  1968-07

7.  Electron microscopic studies on the normal human spleen: especially on the red pulp and the reticulo-endothelial cells.

Authors:  Y Hirasawa; H Tokuhiro
Journal:  Blood       Date:  1970-02       Impact factor: 22.113

8.  Human cytomegalovirus replicates in primary human bone marrow cells.

Authors:  H Reiser; J Kühn; H W Doerr; H Kirchner; K Munk; R Braun
Journal:  J Gen Virol       Date:  1986-12       Impact factor: 3.891

9.  Transmission and activation of cytomegalovirus with blood transfusion: a mouse model.

Authors:  K S Cheung; D J Lang
Journal:  J Infect Dis       Date:  1977-05       Impact factor: 5.226

10.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

View more
  53 in total

1.  Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs.

Authors:  N K Grzimek; D Dreis; S Schmalz; M J Reddehase
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Murine cytomegalovirus m02 gene family protects against natural killer cell-mediated immune surveillance.

Authors:  Sofia A Oliveira; Se-Ho Park; Peter Lee; Albert Bendelac; Thomas E Shenk
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Focal transcriptional activity of murine cytomegalovirus during latency in the lungs.

Authors:  S K Kurz; M Rapp; H P Steffens; N K Grzimek; S Schmalz; M J Reddehase
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 4.  Sources and signals regulating type I interferon production: lessons learned from cytomegalovirus.

Authors:  Shilpi Verma; Chris A Benedict
Journal:  J Interferon Cytokine Res       Date:  2011-01-12       Impact factor: 2.607

5.  Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells.

Authors:  P Simmons; K Kaushansky; B Torok-Storb
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

6.  Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence.

Authors:  H P Steffens; S Kurz; R Holtappels; M J Reddehase
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

7.  A comparative study of congenital and postnatally acquired human cytomegalovirus infection in infants: lack of expression of viral immediate early protein in congenital cases.

Authors:  A Maeda; T Sata; Y Sato; T Kurata
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

8.  Immunosuppression induces transcription of murine cytomegalovirus glycoprotein H in the eye and at non-ocular sites.

Authors:  Y Duan; S S Atherton
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

9.  Lymphoid-tissue stromal cells coordinate innate defense to cytomegalovirus.

Authors:  Shilpi Verma; Qiao Wang; Grzegorz Chodaczek; Chris A Benedict
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

10.  Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice.

Authors:  H W Virgin; R M Presti; X Y Li; C Liu; S H Speck
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.